People affected by Alzheimer's disease are more likely to have low blood levels of vitamin E, as compared to people with normal cognitive function.

Among carriers of the apolipoprotein E (APOE) epsilon-4 genotype, staying active slows the buildup of amyloid plaques in the brain.

Adiponectin, a hormone derived from visceral fat, may play a role as a risk factor for development of all-cause dementia and Alzheimer's Disease in women.

A diet rich in key vitamins and omega-3 fatty acids helps to promote cognitive function, as well as reduce brain shrinkage associated with Alzheimer’s Disease.

German researchers report that a red dye derived from lichens appears to reduce the abundance of small toxic protein aggregates in Alzheimer’s disease.

A diet rich in omega-3 and omega-6 fatty acvids, as well as antioxidant vitamins, may beneficially impact the onset of Alzheimer’s Disease.

Japanese team reports that people with diabetes may be at a significantly increased risk of developing cognitive disorders, including Alzheimer’s Disease.

Japanese researchers reveal that people with high cholesterol may be at higher risk of developing Alzheimer's Disease.

In its “World Alzheimer's Report 2011,” Alzheimer's Disease International encourages efforts for early diagnosis, that may effect society-wide health, financial and social benefits.

Intranasal insulin therapy may have beneficial effects on cognition and function, among patients with Alzheimer's Disease.